Shree Pacetronix (BOM:527005) EBIT: ₹46.2 Mil (TTM As of Mar. 2026)


BOM:527005 Shree Pacetronix Ltd BOM:527005
81 GF Score
Price ₹130.05
GF Value ₹163.21
Valuation Modestly Undervalued
View Full Analysis

What is Shree Pacetronix EBIT?

Shree Pacetronix BOM:527005 -0.19% 81 EBIT is ₹46.2 Mil as of Mar. 2026. GuruFocus rates BOM:527005 with a GF Score™ of 81/100 and a GF Value™ of ₹163.21 (Modestly Undervalued).

Shree Pacetronix's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹14.7 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹46.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shree Pacetronix's annualized ROC % for the quarter that ended in Mar. 2026 was 20.02%. Shree Pacetronix's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 33.68%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shree Pacetronix's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.30%.


Shree Pacetronix  (BOM:527005) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shree Pacetronix's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=56.92 * ( 1 - 21.32% )/( (0 + 223.663)/ 1 )
=44.784656/223.663
=20.02 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Shree Pacetronix's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=58.784/( ( (0 + max(0, 0)) + (45.624 + max(128.924, 0)) )/ 1 )
=58.784/( ( 0 + 174.548 )/ 1 )
=58.784/174.548
=33.68 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(106.367 + 48.275 + 23.059) - (15.554 + 0 + 33.223)
=128.924

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shree Pacetronix's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=46.206/496.631
=9.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shree Pacetronix EBIT Related Terms


Shree Pacetronix EBIT Historical Data

* Premium members only.

The historical data trend for Shree Pacetronix's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Pacetronix EBIT Chart

Shree Pacetronix Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.37 48.67 49.87 16.25 46.21

Shree Pacetronix Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.94 10.08 18.53 2.90 14.70

BOM:527005 vs ISRG, BDX, MDLN: EBIT Comparison

For the Medical Instruments & Supplies subindustry, Shree Pacetronix's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shree Pacetronix EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shree Pacetronix's EV-to-EBIT falls into.


BOM:527005
81GF Score
Shree Pacetronix Ltd BOM:527005
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shree Pacetronix EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹46.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹46.2 Mil mean?
Shree Pacetronix (BOM:527005) has a EBIT of ₹46.2 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shree Pacetronix.
Is Shree Pacetronix's EBIT too high?
Shree Pacetronix's current EBIT is ₹46.2 Mil. Overall, Shree Pacetronix has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's EBIT compare to ISRG and BDX?
Shree Pacetronix's EBIT of ₹46.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Shree Pacetronix. Shree Pacetronix's current EBIT is ₹46.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹163.21, compared to a current price of ₹130.05 — trading 20.3% below its estimated fair value. The current EBIT is ₹46.2 Mil. Shree Pacetronix's overall GF Score™ is 81/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current EBIT is ₹46.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Pacetronix (BOM:527005) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued. The current stock price of ₹130.05 is trading 20.3% below its estimated GF Value™ of ₹163.21. GuruFocus considers Shree Pacetronix to be Modestly Undervalued.

Key valuation signals for BOM:527005:

  • EBIT: ₹46.2 Mil
  • GF Value™: ₹163.21 vs. price of ₹130.05 (20.3% below fair value)
  • GF Score™: 81/100

No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shree Pacetronix Business Description

Address Plot Number 15, Sector II, Industrial Area, District Dhar, Pithampur, MP, IND, 454775
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
81GF Score

Get the complete analysis for BOM:527005

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹130.05
Price
₹163.21
GF Value